BIOEQUIVALENCE BETWEEN INNOVATOR AND GENERIC TACROLIMUS IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED, CROSSOVER CLINICAL TRIAL.



Account has been disabled due to a violation of Terms of Service.

Contact Moderators